drugset / Trial / NCT07777965
Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience
RandomizedCrossoverDouble-blindOther
Summary
The purpose of the present study is to assess prospectively the abuse potential of gabapentin compared to placebo and alprazolam in healthy non-drug-dependent recreational sedative drug users under fasted condition.
Timeline
- Start
- 2026-06-18
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alprazolam | Small molecule | 2 mg | Oral |
| Comparator | Gabapentin | Unknown | 1200 mg | Oral |
| Comparator | Gabapentin | Unknown | 1800 mg | Oral |
Indications
No indication recorded.